A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Clinical trial NCT07463521 · RECRUITING
Trial details
- NCT number
- NCT07463521
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2028-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.